Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity-Reference-Cited by-同舟云学术

Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity

Published:1966-07 Issue:3731 Volume:153 Page:80-82
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Bloom Barry R.¹,Bennett Boyce²

Affiliation:

1. Department of Microbiology and Immunology and Department of Pathology, Albert Einstein College of Medicine, New York 10461

2. Departmnent of Microbiology and Immunology and Department of Pathology, Albert Einstein College of Medicine, New York 10461

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference14 articles.

1. BENNETT, B, SPECIFIC SUPPRESSION OF TUMOR GROWTH BY ISOLATED PERITONEAL MACROPHAGES FROM IMMUNIZED MICE, JOURNAL OF IMMUNOLOGY 95: 656 (1965).

2. Bloom, B. R., Progress in Allergy 10: 151 (1967).

3. BLOOM, B.R., EFFECTS OF MITOMYCIN C ON CELLULAR TRANSFER OF DELAYED-TYPE HYPERSENSITIVITY IN GUINEA PIG, NATURE 201: 689 (1964).

4. BUTLER, W.T., HEMAGGLUTINATION STUDIES WITH FORMALINIZED ERYTHROCYTES - EFFECT OF BIS-DIAZO-BENZIDINE AND TANNIC ACID TREATMENT ON SENSITIZATION BY SOLUBLE ANTIGEN, JOURNAL OF IMMUNOLOGY 90: 663 (1963).

5. DAVID, J.R., SUPPRESSION OF DELAYED HYPERSENSITIVITY IN VITRO BY INHIBITION OF PROTEIN SYNTHESIS, JOURNAL OF EXPERIMENTAL MEDICINE 122: 1125 (1965).

Cited by 1480 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redox-dependent plasticity of oxMIF facilitates its interaction with CD74 and therapeutic antibodies;Redox Biology;2024-09

2. Redox Regulation of K⁺ Channel: Role of Thioredoxin;Antioxidants & Redox Signaling;2024-08-28

3. The enhancer RNA, AANCR, regulates APOE expression in astrocytes and microglia;Nucleic Acids Research;2024-08-20

4. Myeloid Cells in Myocardial Ischemic Injury: The Role of the Macrophage Migration Inhibitory Factor;Life;2024-08-05

5. Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma;Oncotarget;2024-07-19